BioGaia AB (FRA:BGLA)
€ 9.115 -0.035 (-0.38%) Market Cap: 931.59 Mil Enterprise Value: 835.03 Mil PE Ratio: 31.83 PB Ratio: 6.64 GF Score: 95/100

Q4 2022 Biogaia AB Earnings Call Transcript

Feb 03, 2023 / 08:30AM GMT
Release Date Price: €8.64 (+4.60%)
Operator

Welcome to BioGaia Q4 Report 2022. (Operator Instructions) Now I will hand the conference over to the speaker CEO, Isabelle Ducellier. Please go ahead.

Isabelle Valerie Ghislaine Ducellier;publ;CEO;President
BioGaia AB

()-&

Good morning, and welcome to our interim management statement quarter 4 2022. I will as well comment on the whole year '22 prior to the annual report release planned on March 27. So in a nutshell, I will say that we have a strong Q4 with 33% growth in sales and one of the best year of BioGaia at plus 41% sales increase, which allow us for the first time in our 32-year history to pass the SEK 1 billion mark in turnover. And despite the global cost increase, we've been able to maintain our EBIT at 33% even if the Q4 being a bit lower in EBIT margin as it was last year and that's mainly due to the fact that it's a very intense activity in terms of marketing and sales campaign. So the OpEx increase somehow weighs a bit more in Q4 than the rest of the year.

Looking at key events, I just

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot